OBJECTIVES This study assessed trends in transesophageal echocardiography (TEE) use, rate of left atrial appendage (LAA) thrombus detection, and incidence of periprocedural cerebrovascular accident (CVA) since transitioning to a strategy of uninterrupted warfarin or briefly interrupted novel oral anticoagulant therapy in 2010.
for LAA thrombus (1,2). However, there is great variability in the use of TEE before ablation.
Since 2010, a range of studies have suggested that uninterrupted periprocedural anticoagulation with either warfarin or novel oral anticoagulants (NOACs) is an effective approach to minimize CVA risk (3) (4) (5) (6) .
Whether adoption of minimally interrupted anticoagulation obviates the need in some patients to screen for LAA thrombus with TEE or other imaging is not clear. In the current study, we evaluate trends in TEE use, findings, and CVA incidence in 1,224 patients undergoing AF ablation in the era of minimally interrupted periprocedural anticoagulation. POST-PROCEDURE CVA FOLLOW-UP. All patients were monitored overnight in the hospital and clinically evaluated before discharge the following day.
METHODS
Patients in whom neurological deficits were reported or observed underwent brain magnetic resonance imaging for evaluation of CVA. Clinical follow-up was performed routinely at 3 months, 6 months, and 1 year or earlier if the patient reported any symptoms. 
RESULTS
A total of 1,224 AF ablations were performed in 999 patients between January 2010 and September 2015.
Three additional cases were excluded from analysis after aborted attempt at TEE. Baseline characteristics of the study cohort are summarized in Table 1 . Average Balouch et al.
TEE Utility Prior to AF Ablation Values are mean AE SD or n (%).
AF ¼ atrial fibrillation; BMI ¼ body mass index; CVA ¼ cerebrovascular accident; CHA2DS2VASc ¼ congestive heart failure, hypertension, age $75 years, diabetes mellitus, stroke, vascular disease, age 65-74 years, sex category; EF ¼ ejection fraction.
FIGURE 1 Periablation Anticoagulation
Patients undergoing ablation were typically anticoagulated with warfarin or a novel oral anticoagulant, although a small percentage of patients presented for ablation off all anticoagulation.
Balouch et al. There were no episodes of noncerebral thromboembolism. Clinical characteristics and anticoagulation profiles of the CVA patients are summarized in Table 3 . 
DISCUSSION
We investigated trends in pre-procedure TEE acquisition before AF ablation at our institution since Values are mean AE SD or n (%). N ¼ number of cases, n ¼ number of patients.
TEE ¼ transesophageal echocardiography; other abbreviations as in Table 1 .
TEE Utility Prior to AF Ablation Tables 1 and 2 .
Balouch et al. Our practice in 2016 is that TEE before AF ablation is most reasonable in patients with these clinical risks.
Patients presenting in normal sinus rhythm with low CHA 2 DS 2 VASC scores typically are not undergoing TEE before ablation at our institution; patients with persistent AF, even in the setting of a relatively low CHA 2 DS 2 VASC score, typically are referred for TEE, based in part on the sobering finding that 2 of our CVA/ TIA patients had a CHA 2 DS 2 VASC score of 0, but persistent AF. Additionally, our findings that CVAs occurred in 3 patients for whom screening TEE was negative and that all patients with positive screening TEE for LAA thrombus avoided subsequent CVA underscores that particular care must be given to intraprocedural and post-procedural anticoagulation.
We found that presence of LAA thrombus on TEE was associated with increased CHA 2 DS 2 VASC score. Other investigators have reported on foregoing TEE before AF ablation, regardless of CHA 2 DS 2 VASC score or prior CVA history. In a study of 970 patients anticoagulated with either apixaban or rivaroxaban without interruption before AF ablation, Di Biase et al. (14) found that CVA risk was minimal (0.1%) even when TEE screening was entirely eliminated. Of note, more than 70% of this cohort was screened for LAA thrombus with intracardiac echocardiography (ICE) catheter imaging, which limits the general conclusions that can be drawn about elimination of LA imaging altogether.
WHAT IS GAINED BY AVOIDING TEE? TEE is the recommended screening tool in patients with sustained AF for detection of LA/LAA thrombus (2) before restoration of sinus rhythm, with a sensitivity and specificity ranging from 83% to 100%
(1, [15] [16] [17] . However, TEE is somewhat invasive and carries its own risk of potential complications including oropharyngeal, laryngeal, esophageal, and gastric injury (17, 18) . Because TEE is often performed under anesthesia at the time of the ablation procedure, it also increases procedure duration and cost; Tables 1 to 3 .
TEE Utility Prior to AF Ablation to AF patients that is effective and safe is at the core of 2 basic clinical competencies: medical knowledge, patient care and procedural skills. We believe that our investigation allows readers to supplement these 2 competencies, by providing data about whether ancillary procedures (i.e., TEE) around AF ablation is needed, in whom it may be avoided, and what that ancillary procedure is likely to find in a particular patient population.
TRANSLATIONAL OUTLOOK: Making ablation for AF patients a more safe and effective procedure is the subject of active investigation worldwide. This investigation raises impor-
tant questions yet to be tested. Although we found that TEE was of limited value in low-risk patients, the rather obvious question raised by our investigations (and other similar studies) is whether higher-risk groups can forego TEE, and what other strategies (e.g., rigorous anticoagulation monitoring, ICE-catheter assessment, pre-procedure computed tomography or magnetic resonance imaging) might need to be in place to ensure patient safety in the absence of TEE. We anticipate that as preprocedural and intraprocedural imaging options continue to evolve, and as periprocedural uninterrupted anticoagulation becomes a more widely adopted strategy, investigations to determine how best to reduce periprocedural CVA will increase.
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